Author: OurCrowd

[CytoReason in Startup News] Using AI-models to find curse for diseaseCytoReason and the Crohn’s & Colitis Foundation forge groundbreaking data collaboration to advance IBD research[CytoReason in NoCamels] Using AI-models to find curse for disease

CytoReason, a pioneer in developing computational disease for drug development, today announced a strategic collaboration with the Crohn’s & Colitis Foundation. The collaboration aims to empower CytoReason’s analytical capabilities with the Foundation’s IBD Plexus® real-world data platform. This collaboration has the potential to accelerate new discoveries with superior data integration and improve the precision and effectiveness of drug development in inflammatory bowel disease (IBD). Read...

Read More

[IQM in Qauntum Insider] IQM Quantum Computers Collaborates With Hewlett Packard Enterprise And Demonstrates Quantum-HPC Integration

PRESS RELEASE — IQM Quantum Computers (IQM), a global leader in building quantum computers, announced a collaboration and showcase of a joint demo of quantum computing and high-performance computing (HPC) integration at ISC High Performance 2024, the annual international supercomputing conference in Hamburg, with Hewlett Packard Enterprise (HPE), the global edge-to-cloud company. Read...

Read More

[Incredo Sugar in Tech Talks Daily Podcast] Blommer Chocolate Company and Incredo expand their partnership and Broaden their reach to include Canada

Today Blommer Chocolate Company (USA), the largest cocoa processor and ingredient chocolate supplier in North America, and Incredo, Inc. (US), a global food tech company spearheading sugar reduction, announced their plans to extend their partnership and broaden their reach into Canada. Blommer’s Discovery product line, empowered by the award-winning sugar-based sugar reduction solution, Incredo® Sugar includes chocolate-flavored chips and coatings. This line of chocolate ingredients is free from high intensity sweeteners and sugar alcohols.   Read more...

Read More